高盟新材(300200.SZ)2020年度淨利潤預增18.3%-37.2%
格隆匯 1 月 28日丨高盟新材(300200.SZ)公佈,預計2020年度歸屬於上市公司股東的淨利潤2.2億元-2.55億元,同比增長18.3%-37.2%;扣除非經常性損益後的淨利潤21606.17萬元-25106.17萬元,同比增長22.2%-42.0%。
業績變動原因:1、年初,面臨疫情壓力,公司上下齊心,眾志成城,較早實現了復產復工;
2、一方面受益於“大消費”業務,另一方面,公司不斷調整、優化產品結構,提高產品競爭力,全年銷售收入、毛利水平在疫情影響下仍保持在合理、穩定的水平;
3、與此同時,公司淨利潤的較大增長也得益於國家税費優惠政策、公司降本增效、期間費用大幅下降、投資收益增加等因素。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.